Fourth COVID-19 Wave in Myanmar: Over 80,000 New Cases Confirmed, 80% Patients Unvaccinated
Over 80% people who died in Myanmar during the fourth COVID-19 wave were either unvaccinated or got only the first dose of COVID-19 vaccine.
Over 80% people who died in Myanmar during the fourth COVID-19 wave were either unvaccinated or got only the first dose of COVID-19 vaccine.
India's fight against the coronavirus got a major boost, after the Drugs Controller General of India (DCGI) gave its nod to Hyderabad-based Bharat Biotech's intranasal covid vaccine for restricted emergency use in those aged above 18 years.
But how long the protection from the third COVID-19 vaccine dose will last? Are we going to need more boosters in the future?
This Bivalent COVID-19 Vaccine is an adapted version of the Moderna Spikevax COVID-19 vaccine. Meanwhile, Mozambique has lifted mask mandates as Covid-19 situation improves there.
Meanwhile, Delhi reported 620 new COVID-19 infections and two deaths related to the disease on Friday.
The European Medicines Agency is currently testing the COVID-19 vaccine developed by BioNTech and Pfizer.
This research has come from a detailed analysis of about 43 million people aged 13 years and above.
The government has approved the vaccination of CORBEVAX, a booster dose for the coronavirus available at the CoWIN app.
According to the expert, vaccines can not only prevent animals from diseases but also reduce the risk of transferring the disease to humans or other pets.
Bharat Biotech has completed phase III trials for its intranasal COVID-19 vaccine candidate, called BBV154. It's likely to receive regulatory licenses this month.
COVID-19 Booster Dose: The epidemic's threat has deepened due to the increasing corona cases. Let us tell you why it is necessary to have a booster dose of the vaccine.
India's total COVID-19 vaccination coverage has now crossed 200.61 crore. Bill Gates congratulated PM Modi on achieving this milestone.
Novavax's COVID-19 Vaccine is the fourth vaccine authorized for the prevention of viral disease in the US.
Covovax vaccine has already been approved for restricted use in adults and children in the 12-17 age group.
The study found that the neutralising activity against Omicron sub-variants such as BA.1, BA.2, BA.2.11, BA.2.12.1, BA.2.13, and BA.4/BA.5 "was not or only minimally detectable".
Covaxin has proven to be safe, well-tolerated, and highly immunogenic in children and adolescents of 2-18 years age group in phase II/III study.
US FDA approves Moderna And Pfizer COVID-19 vaccines for children under 5, Bharat Biotech confirms safety of Covaxin for 2-year-olds.
ICMR has developed a strategy to use drones to transport COVID-healthcare equipment's to far off regions like Northeast India.
Over 80% people who died in Myanmar during the fourth COVID-19 wave were either unvaccinated or got only the first dose of COVID-19 vaccine.
But how long the protection from the third COVID-19 vaccine dose will last? Are we going to need more boosters in the future?
This Bivalent COVID-19 Vaccine is an adapted version of the Moderna Spikevax COVID-19 vaccine. Meanwhile, Mozambique has lifted mask mandates as Covid-19 situation improves there.
Meanwhile, Delhi reported 620 new COVID-19 infections and two deaths related to the disease on Friday.
The European Medicines Agency is currently testing the COVID-19 vaccine developed by BioNTech and Pfizer.
This research has come from a detailed analysis of about 43 million people aged 13 years and above.
The government has approved the vaccination of CORBEVAX, a booster dose for the coronavirus available at the CoWIN app.
According to the expert, vaccines can not only prevent animals from diseases but also reduce the risk of transferring the disease to humans or other pets.
Bharat Biotech has completed phase III trials for its intranasal COVID-19 vaccine candidate, called BBV154. It's likely to receive regulatory licenses this month.
COVID-19 Booster Dose: The epidemic's threat has deepened due to the increasing corona cases. Let us tell you why it is necessary to have a booster dose of the vaccine.
India's total COVID-19 vaccination coverage has now crossed 200.61 crore. Bill Gates congratulated PM Modi on achieving this milestone.
Novavax's COVID-19 Vaccine is the fourth vaccine authorized for the prevention of viral disease in the US.
Covovax vaccine has already been approved for restricted use in adults and children in the 12-17 age group.
The study found that the neutralising activity against Omicron sub-variants such as BA.1, BA.2, BA.2.11, BA.2.12.1, BA.2.13, and BA.4/BA.5 "was not or only minimally detectable".
Covaxin has proven to be safe, well-tolerated, and highly immunogenic in children and adolescents of 2-18 years age group in phase II/III study.
US FDA approves Moderna And Pfizer COVID-19 vaccines for children under 5, Bharat Biotech confirms safety of Covaxin for 2-year-olds.
ICMR has developed a strategy to use drones to transport COVID-healthcare equipment's to far off regions like Northeast India.
The study, published on Tuesday in the journal PLOS Biology, analysed blood samples being collected from people vaccinated for COVID-19.
Let's take a look at some of the latest developments in COVID-19 research and treatment announced this month (December 2021).
Covid-19 vaccines are here but they come with some mild side effects. Here are some of the easy tips to cope with each of them and stay fit.
India's fight against the coronavirus got a major boost, after the Drugs Controller General of India (DCGI) gave its nod to Hyderabad-based Bharat Biotech's intranasal covid vaccine for restricted emergency use in those aged above 18 years.
Corbevax vaccine, which is made by Biological -E Limited Company of Hyderabad. Biologicals -E Limited is known for the production of Heparin, an anticoagulant injection.
Guidelines for booster shots in India: Watch this video for all you need to know!
World Sight Day: We witness World Sight Day on 14th of October every year. This day is celebrated to raise awareness about blindness and visual impairment.
It is the second Covid 19 vaccine to be approved for emergency use among children after Zydus Healthcare's ZyCoV-D in children for above 12 years. The experts said that efficacy of Covaxin in children has found to be almost similar to that in adults.
Covid-19 Vaccination For Children: As the government has announced the vaccination drive for children to kickstart in October. Watch this to find out more.
Zydus Cadila's needle-free three shot vaccine ' ZyCov-D' to be launched in India in September. Watch this video and get more details on the vaccine.
Whether be it breastfeeding or maternity concerns, many women are still doubtful about vaccinations and are still not sure if lactating mothers can receive a Covid19 vaccine? What could be the impact of Covid19 vaccine on breast feeding mothers?
During the Health Summit 2020 organized by TheHelathSite.com, AIIMS Director Dr Randeep Guleria shed light on the COVAXIN trials in India.
